207940.KS
207940.KS
KR7207940008
SAMSUNG BIOLOGICS
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 4.556.971.695.180 3.497.145.675.780
30.3%
Cost of Revenue 2.040.331.283.530 1.785.960.975.720
14.2%
Gross Profit 2.516.640.411.650 1.711.184.700.060
47.1%
447.419.144.940 389.818.319.400
14.8%
Operating Income 2.069.221.266.710 1.321.366.380.660
56.6%
Pretax Income 2.118.631.252.680 1.384.868.829.740
53.0%
Net Income Common Stockholders 1.784.352.060.590 1.083.315.885.980
64.7%
-- --
--
-- --
--
ende